The consistent finding with previous studies in SMA patients indicates the role of SMN protein depletion in abnormal serum lipid profile, mainly focusing on glucose and fatty acid metabolism abnormalities (Deguise et al., 2019; Djordjevic et al., 2021a). The gene discussed is SMN1; the disease is proximal spinal muscular atrophy.